Citations (116)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Alice L Smart, Simon Gaisford & Abdul W Basit. (2014) Oral peptide and protein delivery: intestinal obstacles and commercial prospects. Expert Opinion on Drug Delivery 11:8, pages 1323-1335.
Read now
Read now
Ingrid Velter, Barbara La Ferla & Francesco Nicotra. (2006) Carbohydrate‐Based Molecular Scaffolding. Journal of Carbohydrate Chemistry 25:2-3, pages 97-138.
Read now
Read now
Richard B van Breemen & Yongmei Li. (2005) Caco-2 cell permeability assays to measure drug absorption. Expert Opinion on Drug Metabolism & Toxicology 1:2, pages 175-185.
Read now
Read now
I.A. Rivero, R. Somanathan & L.H. Hellberg. (1998) Synthesis of 3-Dipeptidyl-2,4(1H,3H)-Quinazolinediones as Potential Anti-Hypertensive Agents. Synthetic Communications 28:11, pages 2077-2086.
Read now
Read now
M. J. Humphrey & D. A. Smith. (1992) Role of metabolism and pharmacokinetic studies in the discovery of new drugs—present and future perspectives. Xenobiotica 22:7, pages 743-755.
Read now
Read now
Articles from other publishers (111)
Jessyca Aparecida Paes Dutra, Sarah Canal Maximino, Rita de Cássia Ribeiro Gonçalves, Pedro Alves Bezerra Morais, William Cezar de Lima Silva, Ricardo Pereira Rodrigues, Álvaro Cunha Neto, Valdemar Lacerda Júnior, Warley de Souza Borges & Rodrigo Rezende Kitagawa. (2022)
Anti‐
Candida
, docking studies, and in vitro metabolism‐mediated cytotoxicity evaluation of Eugenol derivatives
. Chemical Biology & Drug Design 101:2, pages 350-363.
Crossref
Crossref
Zhao Li, Yumeng Zhu & John B. Matson. (2022) pH-Responsive Self-Assembling Peptide-Based Biomaterials: Designs and Applications. ACS Applied Bio Materials 5:10, pages 4635-4651.
Crossref
Crossref
Rishabha Malviya, Swati Verma & Sonali Sundram. (2022) Advancement and Strategies for the Development of Peptide-drug Conjugates:
Pharmacokinetic Modulation, Role and Clinical Evidence against
Cancer Management. Current Cancer Drug Targets 22:4, pages 286-311.
Crossref
Crossref
Philippe E. Nashar, Aidan A. Whitfield, Jiri Mikusek & Tristan A. Reekie. 2022. Oxytocin. Oxytocin
153
174
.
Juan J. Perez. (2021) Exploiting Knowledge on Structure–Activity Relationships for Designing Peptidomimetics of Endogenous Peptides. Biomedicines 9:6, pages 651.
Crossref
Crossref
Enaam Masri, Ahsanullah, Matteo Accorsi & Jörg Rademann. (2020) Side-Chain Modification of Peptides Using a Phosphoranylidene Amino Acid. Organic Letters 22:8, pages 2976-2980.
Crossref
Crossref
Nora Hamad Al-Shaalan, Imran Ali, Zeid A. ALOthman, Lamya Hamad Al-Wahaibi & Hadeel Alabdulmonem. (2020)
Stereomeric resolution and modeling of
dl
-alanine-
dl
-phenyl alanine dipeptide on an AmyCoat-RP column
. Analytical Methods 12:2, pages 162-168.
Crossref
Crossref
Teng Feng, Xiaonan Huang, Rong Ni, Wai Leung Langston Suen & Ying Chau. 2019. Nanomaterials for Drug Delivery and Therapy. Nanomaterials for Drug Delivery and Therapy
149
183
.
Andreas F. B. Räder, Michael Weinmüller, Florian Reichart, Adi Schumacher-Klinger, Shira Merzbach, Chaim Gilon, Amnon Hoffman & Horst Kessler. (2018) Orally Active Peptides: Is There a Magic Bullet?. Angewandte Chemie International Edition 57:44, pages 14414-14438.
Crossref
Crossref
Andreas F. B. Räder, Michael Weinmüller, Florian Reichart, Adi Schumacher-Klinger, Shira Merzbach, Chaim Gilon, Amnon Hoffman & Horst Kessler. (2018) Oral aktive Peptide: Gibt es ein Patentrezept?. Angewandte Chemie 130:44, pages 14614-14640.
Crossref
Crossref
Ruirui Xing, Shukun Li, Ning Zhang, Guizhi Shen, Helmuth Möhwald & Xuehai Yan. (2017) Self-Assembled Injectable Peptide Hydrogels Capable of Triggering Antitumor Immune Response. Biomacromolecules 18:11, pages 3514-3523.
Crossref
Crossref
Jordan D. Poley, Laura M. Braden, Amber M. Messmer, Shona K. Whyte, Ben F. Koop & Mark D. Fast. (2016) Cypermethrin exposure induces metabolic and stress-related gene expression in copepodid salmon lice ( Lepeophtheirus salmonis ). Comparative Biochemistry and Physiology Part D: Genomics and Proteomics 20, pages 74-84.
Crossref
Crossref
Mohammed F. Alajmi, Afzal Hussain, Mohd. Suhail, Sofi Danish Mukhtar, Dibya Ranjan Sahoo, Leonid Asnin & Imran Ali. (2016) Chiral HPLC Separation and Modeling of Four Stereomers of DL-Leucine-DL-Tryptophan Dipeptide on Amylose Chiral Column. Chirality 28:9, pages 642-648.
Crossref
Crossref
Lu-juan Xing, Ya-ya Hu, Hong-yan Hu, Qing-feng Ge, Guang-hong Zhou & Wan-gang Zhang. (2016) Purification and identification of antioxidative peptides from dry-cured Xuanwei ham. Food Chemistry 194, pages 951-958.
Crossref
Crossref
Bhuvaneshwar Vaidya & Shubha Vaidya. 2015. Encyclopedia of Biomedical Polymers and Polymeric Biomaterials. Encyclopedia of Biomedical Polymers and Polymeric Biomaterials
757
775
.
S. Sajeesh & Chandra P. Sharma. 2015. Encyclopedia of Biomedical Polymers and Polymeric Biomaterials. Encyclopedia of Biomedical Polymers and Polymeric Biomaterials
4605
4620
.
Jibin Li, Qing Wang & Ismael J. Hidalgo. 2015. New Horizons in Predictive Drug Metabolism and Pharmacokinetics. New Horizons in Predictive Drug Metabolism and Pharmacokinetics
27
52
.
Imran Ali, Dibya Ranjan Sahoo, Zeid A. ALOthman, Abdulrahman A. Alwarthan, Leonid Asnin & Bernt Larsson. (2015) Validated chiral high performance liquid chromatography separation method and simulation studies of dipeptides on amylose chiral column. Journal of Chromatography A 1406, pages 201-209.
Crossref
Crossref
Imran Ali, Ashanul Haque, Zeid A. Al-Othman, Abdulrahman Al-Warthan & Leonid Asnin. (2014) Stereoselective interactions of chiral dipeptides on amylose based chiral stationary phases. Science China Chemistry 58:3, pages 519-525.
Crossref
Crossref
Grégory Coué & Johan F. J. Engbersen. 2014. Cationic Polymers in Regenerative Medicine. Cationic Polymers in Regenerative Medicine
356
385
.
Ashok K. Kulkarni & Rajendra P. Ojha. (2014)
Combined
1
H-NMR and Molecular Dynamics Studies on Conformational Behavior of a Model Heptapeptide, GRGDSPC
. Chemical Biology & Drug Design 84:5, pages 567-577.
Crossref
Crossref
Imran Ali, Zeid A. Al-Othman, Abdulrahman Al-Warthan, Leonid Asnin & Alexander Chudinov. (2014) Advances in chiral separations of small peptides by capillary electrophoresis and chromatography. Journal of Separation Science 37:18, pages 2447-2466.
Crossref
Crossref
Arnab DeArnab De. 2013. Application of Peptide-Based Prodrug Chemistry in Drug Development. Application of Peptide-Based Prodrug Chemistry in Drug Development
1
13
.
Lutz R. Asmus, Béatrice Kaufmann, Louise Melander, Torsten Weiss, Grégoire Schwach, Robert Gurny & Michael Möller. (2012) Single processing step toward injectable sustained-release formulations of Triptorelin based on a novel degradable semi-solid polymer. European Journal of Pharmaceutics and Biopharmaceutics 81:3, pages 591-599.
Crossref
Crossref
Mine Özyazıcı, Evren Homan Gökçe & Aysu Yurdasiper. 2012. Patenting Nanomedicines. Patenting Nanomedicines
305
343
.
Jie Shen & Diane J. Burgess. 2012. Long Acting Injections and Implants. Long Acting Injections and Implants
73
91
.
BJ Skaggs, EV Lourenço & BH Hahn. (2011) Oral administration of different forms of a tolerogenic peptide to define the preparations and doses that delay anti-DNA antibody production and nephritis and prolong survival in SLE-prone mice. Lupus 20:9, pages 912-920.
Crossref
Crossref
GRÉGORY COUÉ & JOHAN F. J. ENGBERSEN. (2012) PERSPECTIVES ON NANOPARTICULATE DELIVERY OF THERAPEUTIC PROTEINS BY ORAL ADMINISTRATION. Nano LIFE 01:01n02, pages 99-108.
Crossref
Crossref
Zuzana Antosova, Martina Mackova, Vladimir Kral & Tomas Macek. (2009) Therapeutic application of peptides and proteins: parenteral forever?. Trends in Biotechnology 27:11, pages 628-635.
Crossref
Crossref
Amanda K. Petrus, Timothy J. Fairchild & Robert P. Doyle. (2009)
Traveling the Vitamin B
12
Pathway: Oral Delivery of Protein and Peptide Drugs
. Angewandte Chemie International Edition 48:6, pages 1022-1028.
Crossref
Crossref
Amanda K. Petrus, Timothy J. Fairchild & Robert P. Doyle. (2009)
Orale Verabreichung von Protein- und Peptidwirkstoffen entlang der Vitamin-B
12
-Route
. Angewandte Chemie 121:6, pages 1040-1047.
Crossref
Crossref
Rajesh Singh, Shailesh Singh & James W. Lillard. (2008) Past, Present, and Future Technologies for Oral Delivery of Therapeutic Proteins. Journal of Pharmaceutical Sciences 97:7, pages 2497-2523.
Crossref
Crossref
Sajeesh S.Chandra Sharma. 2008. Biomaterials Fabrication and Processing Handbook. Biomaterials Fabrication and Processing Handbook
171
192
.
Joseph C. Kappel, Yi C. Fan & Kit S. Lam. (2008) Global Transformation of OBOC Combinatorial Peptide Libraries into OBOC Polyamine and Small Molecule Libraries. Journal of Combinatorial Chemistry 10:2, pages 333-342.
Crossref
Crossref
Benjamin Guesdon, Michaël Messaoudi, Catherine Lefranc-Millot, Gilles Fromentin, Daniel Tomé & Patrick C. Even. (2006) A tryptic hydrolysate from bovine milk αS1-casein improves sleep in rats subjected to chronic mild stress. Peptides 27:6, pages 1476-1482.
Crossref
Crossref
Xiaohong Qi. (2006) Stochastic Models for Prodrug Targeting. 1. Diffusion of the Efflux Drug. Molecular Pharmaceutics 3:2, pages 187-195.
Crossref
Crossref
Wen‐Ching Ko, Mei‐Li Cheng, Kuo‐Chiang Hsu & Jyh‐Sheng Hwang. (2006) Absorption‐enhancing Treatments for Antihypertensive Activity of Oligopeptides from Tuna Cooking Juice: In Vivo Evaluation in Spontaneously Hypertensive Rats. Journal of Food Science 71:1.
Crossref
Crossref
Bianca M. Liederer, Kimthoa t. Phan, Hui ouyang & Ronald T. Borchardt. (2005) Significant differences in the disposition of cyclic prodrugs of opioid peptides in rats and guinea pigs following IV administration. Journal of Pharmaceutical Sciences 94:12, pages 2676-2687.
Crossref
Crossref
Montree Jaturanpinyo, Atsushi Harada, Xiaofei Yuan & Kazunori Kataoka. (2004) Preparation of Bionanoreactor Based on Core−Shell Structured Polyion Complex Micelles Entrapping Trypsin in the Core Cross-Linked with Glutaraldehyde. Bioconjugate Chemistry 15:2, pages 344-348.
Crossref
Crossref
V.R. Sinha & Aman Trehan. (2003) Biodegradable microspheres for protein delivery. Journal of Controlled Release 90:3, pages 261-280.
Crossref
Crossref
Donald J. AbrahamLuc P. Balant. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
499
532
.
Catriona M H Anderson, Maria E Mendoza, David J Kennedy, Demetrio Raldua & David T Thwaites. (2003)
Inhibition of intestinal dipeptide transport by the neuropeptide VIP is an anti-absorptive effect
via
the VPAC
1
receptor in a human enterocyte-like cell line (Caco-2)
. British Journal of Pharmacology 138:4, pages 564-573.
Crossref
Crossref
Tadashi OgawaMamoru ArakiTetsuhisa MiyamaeToru OkayamaMasaki HagiwaraShinobu Sakurada & Tadanori Morikawa. (2003) Synthesis and Antinociceptive Activity of Orally Active Opioid Peptides: Improvement of Oral Bioavailability by Esterification. Chemical and Pharmaceutical Bulletin 51:7, pages 759-771.
Crossref
Crossref
S Fosset, G Fromentin, D.W Gietzen, M Dubarry, J.F Huneau, J.M Antoine, V Lang, F Mathieu-Casseron & D Tomé. (2002) Peptide fragments released from Phe-caseinomacropeptide in vivo in the rat. Peptides 23:10, pages 1773-1781.
Crossref
Crossref
G Samonina, I Ashmarin & L Lyapina. (2002) Glyproline peptide family: review on bioactivity and possible origins. Pathophysiology 8:4, pages 229-234.
Crossref
Crossref
T Mikolajczyk, I Roelants, P Epler, F Ollevier, J Chyb & B Breton. (2002) Modified absorption of sGNRH-a following rectal and oral delivery to common carp, Cyprinus carpio L.. Aquaculture 203:3-4, pages 375-388.
Crossref
Crossref
Pradip K. Bhatnagar, William F. Huffman, Andrew G. King, Louis M. Pelus, William M. Potts, Philip L. Smith & Dagfinn Løvhaug. 1998. Integration of Pharmaceutical Discovery and Development. Integration of Pharmaceutical Discovery and Development
367
391
.
Mary D. DiBiase & Eric M. Morrel. 2002. Protein Delivery. Protein Delivery
255
288
.
Hyo-Kyung Han & Gordon L. Amidon. (2000) Targeted prodrug design to optimize drug delivery. AAPS PharmSci 2:1, pages 48-58.
Crossref
Crossref
A. Brian Jones, John J. ActonIIIIII, Alan D. Adams, Winston Yuen, Elizabeth A. Nichols, Cheryl D. Schwartz, Linda S. Wicker & Jeffrey D. Hermes. (1999) Tetrapeptide derived inhibitors of complexation of a class II MHC: fully unnatural ligands. Bioorganic & Medicinal Chemistry Letters 9:14, pages 2115-2118.
Crossref
Crossref
Giovanni M. Pauletti. 1999. Advances in Amino Acid Mimetics and Peptidomimetics Volume 2. Advances in Amino Acid Mimetics and Peptidomimetics Volume 2
89
123
.
B. Breton, Y. Roelants, F. Ollevier, P. Epler & T. Mikolajczyk. (1998) Improved bioavailability of orally delivered peptides and polypeptides in teleost fish. Journal of Applied Ichthyology 14:3-4, pages 251-257.
Crossref
Crossref
Charles Y. ChoR. Scott YoungquistSari J. PaikoffMaureen H. BeresiniAndrea R. HebertLea T. BerleauCorey W. LiuDavid E. WemmerThomas KeoughPeter G. Schultz. (1998) Synthesis and Screening of Linear and Cyclic Oligocarbamate Libraries. Discovery of High Affinity Ligands for GPIIb/IIIa. Journal of the American Chemical Society 120:31, pages 7706-7718.
Crossref
Crossref
Kun Han, Myoung Sille Choi & Youn Bok Chung. (1998) Site-specific degradation and transport of recombinant human epidermal growth factor (rhEGF) in the rat gastrointestinal mucosa. International Journal of Pharmaceutics 168:2, pages 189-197.
Crossref
Crossref
Abraham Rubinstein, Boaz Tirosh, Muhammad Baluom, Taher Nassar, Ayelet David, Raphael Radai, Irit Gliko-Kabir & Michael Friedman. (1997) The rationale for peptide drug delivery to the colon and the potential of polymeric carriers as effective tools. Journal of Controlled Release 46:1-2, pages 59-73.
Crossref
Crossref
Sanjeev Gangwar, Giovanni M. Pauletti, Binghe Wang, Teruna J. Siahaan, Valentino J. Stella & Ronald T. Borchardt. (1997) Prodrug strategies to enhance the intestinal absorption of peptides. Drug Discovery Today 2:4, pages 148-155.
Crossref
Crossref
Tarck Aboul‐Fadl & Abdel‐Nasser El‐Shorbagi. (2006) New Carriers for Representative Peptides and Peptide Drugs. Archiv der Pharmazie 330:11, pages 327-332.
Crossref
Crossref
V Marsili, V Nardicchi, G Lupidi, A Brozzetti & G L Gianfranceschi. (1996) Dansylated octapeptide Dns-Glu-Asp-Asp-Ser-Asp-Glu-Glu-Asn inhibits the proliferation rate of HL-60 cells. Canadian Journal of Physiology and Pharmacology 74:12, pages 1302-1307.
Crossref
Crossref
Ismael J. Hidalgo & Jibin Li. (1996) Carrier-mediated transport and efflux mechanisms in Caco-2 cells. Advanced Drug Delivery Reviews 22:1-2, pages 53-66.
Crossref
Crossref
Giovanni M. Pauletti, Sanjeev Gangwar, Gregory T. Knipp, Manoj M. Nerurkar, Franklin W. Okumu, Kiyoshi Tamura, Teruna J. Siahaan & Ronald T. Borchardt. (1996) Structural requirements for intestinal absorption of peptide drugs. Journal of Controlled Release 41:1-2, pages 3-17.
Crossref
Crossref
Elke Walter, Thomas Kissel & Gordon L. Amidon. (1996) The intestinal peptide carrier: A potential transport system for small peptide derived drugs. Advanced Drug Delivery Reviews 20:1, pages 33-58.
Crossref
Crossref
Gitte Juel Friis, Annette Bak, Bjarne Due Larsen & Sven Frøkjær. (1996) Prodrugs of peptides obtained by derivatization of the C-terminal peptide bond in order to effect protection against degradation by carboxypeptidases. International Journal of Pharmaceutics 136:1-2, pages 61-69.
Crossref
Crossref
M NAVIA & P CHATURVEDI. (1996) Design principles for orally bioavailable drugs. Drug Discovery Today 1:5, pages 179-189.
Crossref
Crossref
Reza Oliyai. (1996) Prodrugs of peptides and peptidomimetics for improved formulation and delivery. Advanced Drug Delivery Reviews 19:2, pages 275-286.
Crossref
Crossref
Lorin A. Thompson & Jonathan A. Ellman. (1996) Synthesis and Applications of Small Molecule Libraries. Chemical Reviews 96:1, pages 555-600.
Crossref
Crossref
Jens F Poschet & Steve M HammondPeter D.^Fairclough. (1996) Characterisation of penicillin-G uptake in rabbit small-intestinal brush-border membrane vesicles. Biochimica et Biophysica Acta (BBA) - Biomembranes 1278:2, pages 233-240.
Crossref
Crossref
Ronald T. Borchardt, Philip L. Smith & Glynn Wilson. 1996. Models for Assessing Drug Absorption and Metabolism. Models for Assessing Drug Absorption and Metabolism
1
11
.
John Bird, Gregory P. Harper, Ian Hughes, David J. Hunter, Eric H. Karran, Roger E. Markwell, Anette J. Miles-Williams, Shahzad S. Rahman & Robert W. Ward. (1995) Inhibitors of human collagenase: dipeptide mimetics with lactam and azalactam moieties at the position. Bioorganic & Medicinal Chemistry Letters 5:22, pages 2593-2598.
Crossref
Crossref
Sheng-Fang Su & Gordon L. Amidon. (1995) Investigation into the intestinal metabolism of [d-Ala1] Peptide T amide: implication for oral drug delivery. Biochimica et Biophysica Acta (BBA) - General Subjects 1245:1, pages 62-68.
Crossref
Crossref
David T. Thwaites, Gillian Armstrong, Barry H. Hirst & Nicholas L. Simmons. (2012)
D‐Cycloserine transport in human intestinal epithelial (Caco‐2) cells: mediation by a H
+
‐coupled amino acid transporter
. British Journal of Pharmacology 115:5, pages 761-766.
Crossref
Crossref
Francis Y. Chung & Maureen D. Donovan. (1995) Presystemic Bradykinin Metabolism in Sheep and Rat Nasal Homogenates. Journal of Pharmaceutical Sciences 84:7, pages 794-798.
Crossref
Crossref
Jeffery A. Zablocki, Foe S. Tjoeng, Philippe R. Bovy, Masateru Miyano, Robert B. Garland, Kenneth Williams, Lori Schretzman, Mark E. Zupec, Joseph G. Rico, Richard J. Lindmark, Mihaly V. Toth, Dudley E. McMackins, Steven P. Adams, Susan G. Panzer-Knodle, Nancy S. Nicholson, Beatrice B. Taite, Anita K. Salyers, Lucy W. King, James G. Campion & Larry P. Feigen. (1995) A novel series of orally active antiplatelet agents. Bioorganic & Medicinal Chemistry 3:5, pages 539-551.
Crossref
Crossref
David T. Thwaites, Megan Cavet, Barry H. Hirst & Nicholas L. Simmons. (2012) Angiotensin‐converting enzyme (ACE) inhibitor transport in human intestinal epithelial (Caco‐2) cells. British Journal of Pharmacology 114:5, pages 981-986.
Crossref
Crossref
Edmund J. Moran, Troy E. Wilson, Charles Y. Cho, Sara R. Cherry & Peter G. Schultz. (2004) Novel biopolymers for drug discovery. Biopolymers 37:3, pages 213-219.
Crossref
Crossref
Kornelia Ziegler, Corinna Kolac & Werner Ising. (1994) ATP-dependent transport of the linear renin-inhibiting peptide EMD 51921 by canalicular plasma membrane vesicles of rat liver: evidence of drug-stimulatable ATP-hydrolysis. Biochimica et Biophysica Acta (BBA) - Biomembranes 1196:2, pages 209-217.
Crossref
Crossref
A.K. Salyers, J.A. Szalony, B.B. Taite, N.F. Haas, D.V. Mehrotra, L.P. Feigen & N.S. Nicholson. (1994) A new method for measurement of plasma concentration of orally active glycoprotein IIb/IIIa antagonists. Thrombosis Research 75:4, pages 409-417.
Crossref
Crossref
P.L. Smith, S.E. Yeulet, D.R. Citerone, F. Drake, M. Cook, D.A. Wall & J. Marcello. (1994) SK&F 110679: comparison of absorption following oral or respiratory administration. Journal of Controlled Release 28:1-3, pages 67-77.
Crossref
Crossref
J.F. Tschopp, W.S. Craig, J. Tolley, J. Blevitt, C. Mazur & M.D. Pierschbacher. 1994. Extracellular Matrix Components. Extracellular Matrix Components
556
569
.
C. McMartin. 1994. Pharmacokinetics of Drugs. Pharmacokinetics of Drugs
371
382
.
Renata E. Bluhm, Marshall G. Frazer, Mary Vore, C. Wright Pinson & Kamal F. Badr. (1993) Endothelins 1 and 3: Potent cholestatic agents secreted and excreted by the liver that interact with cyclosporine. Hepatology 18:4, pages 961-968.
Crossref
Crossref
H. Hamilton, B. Steinbaugh, J. Blankley, M. Taylor, O.H. Chan, B. Stewart, R. Schroeder, M. Ryan, S. Rapundalo, J. Cook, A. Bernabei & C. Stewart. (1993) Evaluation of the intestinal permeability and hepatic handling of peptidomimetic analogs. Bioorganic & Medicinal Chemistry Letters 3:5, pages 813-818.
Crossref
Crossref
Anne H. Kahns, Gitte J. Friis & Hans Bundgaard. (1993) Protection of the peptide bond against α-chymotrypsin by the prodrug approach. Bioorganic & Medicinal Chemistry Letters 3:5, pages 809-812.
Crossref
Crossref
Jane P.F. Bai. (1993) Distribution of brush-border membrane peptidases along the rabbit intestine: Implication for oral delivery of peptide drugs. Life Sciences 52:11, pages 941-947.
Crossref
Crossref
Diane J. Burgess. 1993. Biotechnology and Pharmacy. Biotechnology and Pharmacy
116
151
.
Geoffrey B. Dreyer, Dennis M. Lambert, Thomas D. Meek, Thomas J. Carr, Thaddeus A. TomaszekJr.Jr., Annabellee V. Fernandez, Henry Bartus, Emilio Cacciavillani & Anne M. Hassell. (2002) Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, x-ray crystallography, and infected T-cell assays. Biochemistry 31:29, pages 6646-6659.
Crossref
Crossref
Hans Bundgaard. (1992) The utility of the prodrug approach to improve peptide absorption. Journal of Controlled Release 21:1-3, pages 63-72.
Crossref
Crossref
G. Flicker, J. Drewe, J. Vonderscher, T. Kissel & C. Beglinger. (2012) Enteral absorption of octreotide. British Journal of Pharmacology 105:4, pages 783-786.
Crossref
Crossref
Philip L. Smith, Doris A. Wall, Caroline H. Gochoco & Glynn Wilson. (1992) (D) Routes of delivery: Case studies. Advanced Drug Delivery Reviews 8:2-3, pages 253-290.
Crossref
Crossref
COLIN McMARTIN. 1992.
39
106
.
E. Scott Swenson & William J. Curatolo. (1992) (C) Means to enhance penetration. Advanced Drug Delivery Reviews 8:1, pages 39-92.
Crossref
Crossref
Hans Bundgaard. (1992) (C) Means to enhance penetration. Advanced Drug Delivery Reviews 8:1, pages 1-38.
Crossref
Crossref
Boubakar Ba, Gudrun Eckert & Joachim Leube. (1991) Use of dabsylation, column switching and chiral separation for the determination of a renin inhibitor in rat, marmoset and human plasma. Journal of Chromatography B: Biomedical Sciences and Applications 572:1-2, pages 277-289.
Crossref
Crossref
Gitte Juel Rasmussen & Hans Bundgaard. (1991) Prodrugs of peptides. 15. 4-Imidazolidinone prodrug derivatives of enkephalins to prevent aminopeptidase-catalyzed metabolism in plasma and absorptive mucosae. International Journal of Pharmaceutics 76:1-2, pages 113-122.
Crossref
Crossref
Anne H. Kahns & Hans Bundgaard. (1991) Prodrugs of peptides. 14. Bioreversible derivatization of the tyrosine phenol group to effect protection of tyrosyl peptides against α-chymotrypsin. International Journal of Pharmaceutics 76:1-2, pages 99-112.
Crossref
Crossref
X.H. Zhou & A. Li Wan Po. (1991) Peptide and protein drugs: I. Therapeutic applications, absorption and parenteral administration. International Journal of Pharmaceutics 75:2-3, pages 97-115.
Crossref
Crossref
Xin Hua Zhou & Alain Li Wan Po. (1991) Comparison of enzyme activities of tissues lining portals of absorption of drugs: Species differences. International Journal of Pharmaceutics 70:3, pages 271-283.
Crossref
Crossref
Gitte Juel Rasmussen & Hans Bundgaard. (1991) Prodrugs of peptides. 10. Protection of di- and tripeptides against aminopeptidase by formation of bioreversible 4-imidazolidinone derivatives. International Journal of Pharmaceutics 71:1-2, pages 45-53.
Crossref
Crossref
Susan G. DePaolis, William G. Earley, James A. Gainor, Thomas D. Gordon, Barry A. Morgan, Edward D. Pagani & Jasbir Singh. 1991. Peptides 1990. Peptides 1990
380
382
.
P. Raddatz, A. Jonczyk, C. J. Schmitges & J. Sombroek. 1992. Structure and Function of the Aspartic Proteinases. Structure and Function of the Aspartic Proteinases
387
390
.
Doron I. Friedman & Gordon L. Amidon. (1990) Characterization of the intestinal transport parameters for small peptide drugs. Journal of Controlled Release 13:2-3, pages 141-146.
Crossref
Crossref
J. C. Verhoef, H. E. Boddé, A. G. de Boer, J. A. Bouwstra, H. E. Junginger, F. W. H. M. Merkus & D. D. Breimer. (1990) Transport of peptide and protein drugs across biological membranes. European Journal of Drug Metabolism and Pharmacokinetics 15:2, pages 83-93.
Crossref
Crossref
William J. Greenlee. (2006) Renin inhibitors. Medicinal Research Reviews 10:2, pages 173-236.
Crossref
Crossref
Duane B. Lakings, Janice M. Friis & Margie B. Bruns. (1990) Determination of ditekiren, a renin inhibitor peptide, in monkey serum using high-performance liquid chromatography with solid-phase extraction. Journal of Chromatography B: Biomedical Sciences and Applications 526, pages 273-281.
Crossref
Crossref
Vincent H.L. Lee & Akira Yamamoto. (1989) Penetration and enzymatic barriers to peptide and protein absorption. Advanced Drug Delivery Reviews 4:2, pages 171-207.
Crossref
Crossref
S. Lundin, H.‐I. Bengtsson, H. G. Folkesson & B. R. Weström. (2009)
Degradation of [Mercaptopropionic acid
1
, D‐arginine
8
] ‐ vasopressin (dDAVP) in Pancreatic Juice and Intestinal Mucosa Homogenate
. Pharmacology & Toxicology 65:2, pages 92-95.
Crossref
Crossref
Havar Knutsen, Lars Oystein Dolva, Sverre Skrede, Roald Bjorklund & Jorg Morland. (1989) Thyrotropin-releasing Hormone Antagonism of Ethanol Inebriation. Alcoholism: Clinical and Experimental Research 13:3, pages 365-370.
Crossref
Crossref
Judi Møss & Hans Bundgaard. (1989) Prodrugs of peptides. 5. Protection of the pyroglutamyl residue against pyroglutamyl aminopeptidase by bioreversible derivatization with glyoxylic acid derivatives. International Journal of Pharmaceutics 52:3, pages 255-263.
Crossref
Crossref
Hans Bundgaard & Judi Møss. (1989) Prodrugs of Peptides IV: Bioreversible Derivatization of the Pyroglutamyl Group by N-Acylation and N-Aminomethylation to Effect Protection against Pyroglutamyl Aminopeptidase. Journal of Pharmaceutical Sciences 78:2, pages 122-126.
Crossref
Crossref
Ewoud J. van Hoogdalem, Albertus G. de Boer & Douwe D. Breimer. (1989) Intestinal drug absorption enhancement: An overview. Pharmacology & Therapeutics 44:3, pages 407-443.
Crossref
Crossref
Anders Buur & Hans Bundgaard. (1988) Prodrugs of peptides. International Journal of Pharmaceutics 46:1-2, pages 159-167.
Crossref
Crossref
M. J. Humphrey. 1986. Delivery Systems for Peptide Drugs. Delivery Systems for Peptide Drugs
139
151
.